Col1a2-KO 基因敲除小鼠

1. Huang, Kai, Zhang, Xinying, Duan, Jiahao, Yang, Chun, Yang, Ling. 2022. STAT4 and COL1A2 are potential diagnostic biomarkers and therapeutic targets for heart failure comorbided with depression. In Brain research bulletin, 184, 68-75. doi:10.1016/j.brainresbull.2022.03.014. https://pubmed.ncbi.nlm.nih.gov/35367598/

2. Bowers, Stephanie L K, Meng, Qinghang, Kuwabara, Yasuhide, Yutzey, Katherine E, Molkentin, Jeffery D. 2023. Col1a2-Deleted Mice Have Defective Type I Collagen and Secondary Reactive Cardiac Fibrosis with Altered Hypertrophic Dynamics. In Cells, 12, . doi:10.3390/cells12172174. https://pubmed.ncbi.nlm.nih.gov/37681905/

3. Wang, Yi, Sakaguchi, Maki, Sabit, Hemragul, Ohtsuki, Sumio, Nakada, Mitsutoshi. 2022. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion. In Journal of neurosurgery, 138, 639-648. doi:10.3171/2022.6.JNS22319. https://pubmed.ncbi.nlm.nih.gov/35932265/

4. Yuan, Xia, He, Yi, Wang, Wei. 2023. ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma. In Scientific reports, 13, 16932. doi:10.1038/s41598-023-43507-x. https://pubmed.ncbi.nlm.nih.gov/37805556/